BOARD OF DIRECTORS
Mike Zhou was appointed director of the Company on May 26, 2021. From 2019 to the present, Mr. Zhou has served as owner and President of MYZ Corporate Relations Ltd., a private investment and consulting firm that is primarily involved with the North American capital markets. From 2017 to 2018. Mr. Zhou was an Analyst and Associate with PI Financial, a privately-owned Canadian brokerage firm, where he worked directly with the firm’s Vice President and Managing Director. From 2013 to 2015, he was Corporate Development Manager for BiYond Corp., an IoT services company. Mr. Zhou has been a member of the board of directors of the following Canadian public company: Explorex Resource Inc. (which is now known as Raffles Financial Group), a natural resources exploration company from August 15, 2019 to April 16, 2021. Mr. Zhou holds the Project Management Professional designation from the Project Management Institute, and a Bachelor of Science Degree in Statistics and Economics with Minor in Commerce (Saunders School of Business) from the University of British Columbia.
Mr.Zhou’s accumulated experience in international business strategy, the capital markets, and the technology sector, as well as his management positions and director roles in the financial-technology, digital marketing, consulting, and financial sectors, makes him qualified to serve on our Board.
WILLIAM (BILL) F. ESPLEY
William Espley was appointed director of the company in October 2017. From 2003-2010, Mr. Expley was a founding investor in, and served as Investor Relations principal for, Net 1 UEPS Technologies, Nasdaq-listed payment systems provider. Mr. Espley was also a member of the board of directors of American Bullion Minerals Ltd., a mining claims company, from 2008 to 2011, and was its Vice President from 1997 to 2002. He is currently the President and a director of White Tiger Venture Group Ltd., a position he has held since 2015, and the President and a director of Predictive Health Analytics Inc., a position he has held since 2017. From 1994 to 1996, Mr. Espley was a licensed registered representative for C.M. Oliver & Co., a member firm of all of the Canadian stock exchanges. Prior to that, Mr. Espley was a founder and served as President of Professional Canadian Investment Group Inc. (PROCAN), a venture capital company that funded technology and oil & gas companies, from 1985 to 1994.
Mr. Espley’s expertise in business acquisition planning and financing, as well as his venture capital, investor relations and board experience, all qualify him to serve on our Board.
Julie Hajduk was appointed director of the Company on July 28, 2022. Ms. Hajduk is currently the President and CEO of Li-FT Power, a CSE-listed mineral exploration company, a position she has held since May 2021, and since August 2020 has also been CEO of Prince Capital Corp, an exempt market dealer. Ms. Hajduk has served on the board of directors of several public companies over the last 20 years including, most recently, Element 79 Gold Corp from March 2020 until June 2022. Since April 2021 she has also been a director of Little Fish Acquisition I Corp. a Canadian public company formed to identify and evaluate assets or businesses for acquisition. Ms. Hajduk was also director of Opawica Exploration Inc,, a Canadian junior exploration company, from January 2019 to October 2020, and BioCure Technology Inc., a biopharmaceutical company, from January 2012 to February 2019. She founded her own PR and Communications firm, Purple Crown Communications 10 years ago and in that role, she has proven to be an asset to clients by assisting in raising non-brokered and brokered capital for clients along with making sure their news and communications strategies are compliant with regulatory bodies.
Ms. Hajduk’s current role as a CEO for Li-FT Power, Prince Capital Corp., and Purple Crown along with her experience as a multifaceted investor relations specialist and having been a Board member of multiple CSE and dual listed companies qualifies her to serve on our Board.
David Diamond was appointed director of the company on July 28, 2022. Mr. Diamond is currently Managing Director of CBIZ, a Nasdaq-listed provider of accounting, tax, and advisory services, a position he has held since January 2005. He is also a member of the board of directors of RenovoRX, a Nasdaq-listed clinical-stage biopharmaceutical company, where he is the Lead Independent Director and the Chair of its Audit Committee. He has been a member of the board of directors of Vaneltix Pharma, a pharmaceutical company, since June 2022, and was a member of board of directors of Oncotelic, an immuno-oncology company, from June 2020 to July 2021. Mr. Diamond has over 30 years of experience in industry and in public accounting, including expanding two local CPA firms in San Diego and selling them to national CPA firms. He is an active CPA, is a former auditor, and is current on FASB issues and changes in the accounting industry.
Mr. Diamond’s significant experience assisting management teams and board directors with capital financing and strategic business planning, and his deep expertise in accounting matters, qualify him to serve on our Board.